Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (462)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
20
2023
354
3.100
 Why?
Anus Neoplasms
10
2023
24
2.240
 Why?
Stroke
6
2024
492
1.720
 Why?
Acquired Immunodeficiency Syndrome
11
2022
54
1.690
 Why?
Prostatic Hyperplasia
10
2015
39
1.520
 Why?
Brain
8
2024
1309
1.440
 Why?
Parkinson Disease
2
2023
152
1.340
 Why?
Randomized Controlled Trials as Topic
8
2024
553
1.300
 Why?
Chlamydia Infections
8
2017
77
1.270
 Why?
Sarcoma, Kaposi
12
2022
72
1.100
 Why?
Papillomavirus Infections
5
2022
155
1.080
 Why?
Chlamydia trachomatis
6
2017
30
1.070
 Why?
Lymphoma, AIDS-Related
10
2020
16
1.040
 Why?
Brain Ischemia
2
2023
161
0.950
 Why?
Mesenchymal Stem Cell Transplantation
1
2024
18
0.940
 Why?
Plant Extracts
5
2013
190
0.940
 Why?
Serenoa
5
2013
7
0.910
 Why?
Humans
99
2024
49827
0.870
 Why?
Rural Population
4
2023
535
0.850
 Why?
Phytotherapy
3
2012
44
0.830
 Why?
Umbilical Cord
2
2020
35
0.830
 Why?
Middle Aged
50
2021
11997
0.760
 Why?
Lymphoma, Non-Hodgkin
6
2021
62
0.750
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
987
0.750
 Why?
Research Design
5
2022
343
0.730
 Why?
Fetal Blood
2
2019
67
0.690
 Why?
Male
60
2024
25093
0.690
 Why?
Adult
48
2022
13160
0.670
 Why?
Infarction, Middle Cerebral Artery
4
2024
40
0.660
 Why?
Inflammation
3
2021
604
0.650
 Why?
Rats
8
2024
3300
0.650
 Why?
Patient Participation
1
2018
66
0.620
 Why?
Vaginosis, Bacterial
2
2015
8
0.580
 Why?
Decision Making
1
2018
262
0.550
 Why?
Neoplasms
3
2023
1233
0.540
 Why?
Mammography
1
2016
96
0.540
 Why?
Antineoplastic Agents
9
2023
1172
0.520
 Why?
Aged
28
2020
9272
0.510
 Why?
Female
47
2024
26329
0.510
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
47
0.500
 Why?
Population Density
1
2014
15
0.490
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.490
 Why?
AIDS-Related Opportunistic Infections
5
2016
40
0.490
 Why?
Carcinoma in Situ
3
2013
73
0.470
 Why?
Rats, Sprague-Dawley
7
2024
1595
0.460
 Why?
Cytokines
5
2023
612
0.460
 Why?
Anti-Bacterial Agents
5
2020
743
0.450
 Why?
Neonatal Abstinence Syndrome
2
2024
22
0.450
 Why?
Uterine Cervicitis
1
2013
3
0.450
 Why?
Animals
14
2024
13150
0.440
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.440
 Why?
Urethritis
2
2012
5
0.440
 Why?
Finasteride
4
2015
4
0.420
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
105
0.420
 Why?
Guideline Adherence
1
2013
132
0.420
 Why?
Research Subjects
1
2013
50
0.420
 Why?
Breast Neoplasms
3
2017
1169
0.410
 Why?
Subarachnoid Hemorrhage
1
2012
65
0.400
 Why?
Patient Dropouts
1
2012
53
0.400
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
152
0.400
 Why?
Urologic Diseases
1
2011
10
0.390
 Why?
HIV-1
6
2020
55
0.380
 Why?
Lung Neoplasms
2
2013
605
0.370
 Why?
Stem Cell Transplantation
2
2023
181
0.360
 Why?
Disease Models, Animal
5
2024
1451
0.360
 Why?
United States
10
2023
4838
0.360
 Why?
Analgesics, Opioid
3
2024
532
0.350
 Why?
Young Adult
16
2018
3936
0.350
 Why?
Patient Selection
1
2011
251
0.350
 Why?
Quality of Life
6
2024
833
0.340
 Why?
Lymphedema
2
2022
41
0.340
 Why?
Asthma
2
2024
283
0.340
 Why?
HIV Seropositivity
3
2021
26
0.340
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.330
 Why?
Intestinal Mucosa
2
2021
225
0.330
 Why?
Polymorphism, Single Nucleotide
3
2017
485
0.320
 Why?
Gonorrhea
2
2020
9
0.310
 Why?
Azithromycin
4
2020
25
0.310
 Why?
Stem Cells
2
2019
171
0.300
 Why?
Risk Factors
8
2022
3619
0.290
 Why?
Th1 Cells
2
2017
51
0.290
 Why?
Vascular Endothelial Growth Factor A
4
2017
201
0.270
 Why?
Treatment Outcome
17
2020
5138
0.270
 Why?
Mycoplasma genitalium
2
2018
2
0.270
 Why?
Doxazosin
3
2015
3
0.270
 Why?
Mycoplasma Infections
2
2018
7
0.260
 Why?
Prospective Studies
11
2022
2344
0.260
 Why?
Doxycycline
3
2015
32
0.260
 Why?
Anti-Infective Agents
2
2020
97
0.260
 Why?
Cyclophosphamide
9
2021
165
0.260
 Why?
Cancer Vaccines
1
2006
78
0.260
 Why?
Vincristine
8
2021
89
0.250
 Why?
Multicenter Studies as Topic
4
2024
84
0.250
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
553
0.250
 Why?
Adolescent
13
2022
6340
0.240
 Why?
Air Filters
1
2024
1
0.240
 Why?
Double-Blind Method
4
2013
674
0.240
 Why?
Thymus Gland
2
2021
42
0.240
 Why?
Air Pollution, Indoor
1
2024
25
0.230
 Why?
CD4 Lymphocyte Count
7
2020
32
0.230
 Why?
Prevalence
6
2021
943
0.230
 Why?
Bronchiolitis
1
2024
27
0.230
 Why?
5-alpha Reductase Inhibitors
2
2015
3
0.230
 Why?
Homosexuality, Male
3
2022
49
0.230
 Why?
Hyperbaric Oxygenation
1
2023
14
0.230
 Why?
Substantia Nigra
1
2023
14
0.230
 Why?
Doxorubicin
8
2021
230
0.230
 Why?
alpha-Synuclein
1
2023
10
0.230
 Why?
Transplantation Conditioning
2
2018
83
0.220
 Why?
Nervous System Diseases
1
2024
88
0.220
 Why?
Informatics
1
2023
8
0.220
 Why?
Tumor Necrosis Factor-alpha
2
2017
388
0.220
 Why?
Herpesvirus 8, Human
5
2020
91
0.220
 Why?
Prednisone
7
2021
99
0.220
 Why?
Cross-Sectional Studies
3
2021
1541
0.210
 Why?
Follow-Up Studies
8
2019
2179
0.210
 Why?
Brachytherapy
1
2022
48
0.210
 Why?
Astrocytes
1
2024
145
0.210
 Why?
Child
8
2024
6824
0.210
 Why?
Watchful Waiting
1
2022
27
0.210
 Why?
Feasibility Studies
2
2021
374
0.210
 Why?
Medical Records
1
2022
83
0.210
 Why?
Absorptiometry, Photon
1
2003
154
0.210
 Why?
Substance Withdrawal Syndrome
1
2023
168
0.200
 Why?
Vitamin D Deficiency
1
2022
44
0.200
 Why?
Genome-Wide Association Study
3
2018
166
0.200
 Why?
Viral Load
6
2020
76
0.200
 Why?
Brain Injuries
1
2023
160
0.200
 Why?
Vaccines
1
2022
50
0.200
 Why?
Case-Control Studies
3
2014
1128
0.200
 Why?
Precancerous Conditions
1
2022
83
0.200
 Why?
Vaccination
3
2022
268
0.200
 Why?
Mouth Diseases
1
2021
5
0.200
 Why?
Clinical Trials as Topic
5
2020
460
0.200
 Why?
Lymphocyte Activation
3
2017
172
0.200
 Why?
Papillomaviridae
2
2016
102
0.200
 Why?
Mass Screening
2
2015
351
0.190
 Why?
Primary Health Care
2
2022
353
0.190
 Why?
Pluripotent Stem Cells
1
2021
6
0.190
 Why?
Neoplasm Staging
4
2022
746
0.190
 Why?
Physical Conditioning, Animal
1
2021
51
0.190
 Why?
T-Lymphocyte Subsets
2
2017
38
0.190
 Why?
Drug Therapy, Combination
5
2015
378
0.190
 Why?
Papillomavirus Vaccines
2
2013
61
0.190
 Why?
Cross-Over Studies
1
2021
224
0.190
 Why?
Vagina
2
2018
45
0.190
 Why?
Etoposide
5
2021
72
0.190
 Why?
Anti-HIV Agents
3
2020
42
0.180
 Why?
Spleen
1
2021
173
0.180
 Why?
Enzyme Inhibitors
2
2016
391
0.180
 Why?
Genes, myc
1
2020
40
0.180
 Why?
Gene Frequency
2
2017
94
0.180
 Why?
Transplantation, Autologous
3
2018
456
0.180
 Why?
Overweight
1
2022
219
0.180
 Why?
Aged, 80 and over
5
2013
3125
0.180
 Why?
Cell Differentiation
2
2021
653
0.170
 Why?
Uterine Cervical Neoplasms
1
2022
274
0.170
 Why?
Dihydroxyphenylalanine
1
2019
5
0.170
 Why?
Dopaminergic Neurons
1
2019
18
0.170
 Why?
Empathy
1
2019
46
0.170
 Why?
Ablation Techniques
1
2019
20
0.170
 Why?
Social Environment
1
2019
80
0.160
 Why?
Altruism
1
2018
12
0.160
 Why?
Central Nervous System Diseases
1
2019
27
0.160
 Why?
Sodium, Dietary
1
2019
26
0.160
 Why?
Mitochondria
2
2020
397
0.160
 Why?
Asymptomatic Infections
1
2018
6
0.160
 Why?
Dopamine
1
2019
171
0.160
 Why?
Antiviral Agents
2
2013
174
0.160
 Why?
Acoustic Stimulation
1
2018
97
0.160
 Why?
Sexually Transmitted Diseases
1
2018
36
0.160
 Why?
Enzyme-Linked Immunosorbent Assay
3
2017
245
0.160
 Why?
Energy Metabolism
1
2020
281
0.150
 Why?
Hyperthermia, Induced
1
2019
118
0.150
 Why?
Chlamydia
1
2017
8
0.150
 Why?
Protein Kinase Inhibitors
2
2023
202
0.150
 Why?
Mucous Membrane
1
2017
28
0.150
 Why?
Blood Cells
1
2017
43
0.150
 Why?
Pilot Projects
3
2019
699
0.150
 Why?
Biopsy
2
2022
582
0.150
 Why?
Genetic Predisposition to Disease
2
2018
510
0.150
 Why?
Antibodies, Bacterial
1
2017
27
0.150
 Why?
DNA, Circular
1
2017
18
0.150
 Why?
Clostridium Infections
1
2018
55
0.150
 Why?
Clonal Evolution
1
2017
56
0.140
 Why?
Immunoglobulins
1
2017
79
0.140
 Why?
Immunoglobulin G
1
2017
186
0.140
 Why?
Telemedicine
1
2022
443
0.140
 Why?
Anus Diseases
1
2016
2
0.140
 Why?
Sentinel Lymph Node Biopsy
1
2017
116
0.140
 Why?
Mannitol
1
2016
14
0.140
 Why?
Lymph Node Excision
1
2017
136
0.140
 Why?
Thiazoles
1
2016
51
0.130
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
8
0.130
 Why?
Guidelines as Topic
1
2016
111
0.130
 Why?
Diagnostic Self Evaluation
1
2015
13
0.130
 Why?
Comorbidity
2
2018
618
0.130
 Why?
Blood-Brain Barrier
1
2016
48
0.130
 Why?
Anal Canal
3
2023
21
0.130
 Why?
Infant, Newborn
4
2024
2744
0.130
 Why?
Educational Status
1
2016
222
0.130
 Why?
CD4-Positive T-Lymphocytes
1
2017
163
0.130
 Why?
Tinidazole
2
2012
2
0.130
 Why?
Dose-Response Relationship, Drug
4
2013
1374
0.130
 Why?
T-Lymphocytes
1
2017
338
0.130
 Why?
Imidazoles
1
2016
119
0.130
 Why?
Burkitt Lymphoma
1
2015
28
0.130
 Why?
Drug Administration Schedule
5
2020
376
0.130
 Why?
Lymph Nodes
1
2017
264
0.120
 Why?
Menarche
1
2014
7
0.120
 Why?
Stomatitis
1
2014
16
0.120
 Why?
Chromosomes, Human, Pair 2
1
2014
25
0.120
 Why?
Data Collection
3
2023
279
0.120
 Why?
Immunophenotyping
2
2017
109
0.120
 Why?
Obesity
3
2022
1113
0.120
 Why?
Disease-Free Survival
5
2016
457
0.120
 Why?
Hypogonadism
1
2013
10
0.120
 Why?
Benzamides
1
2013
51
0.110
 Why?
Carcinoma, Squamous Cell
1
2016
319
0.110
 Why?
Stress Disorders, Post-Traumatic
1
2018
357
0.110
 Why?
Incidence
4
2018
1003
0.110
 Why?
Heart Failure
1
2019
454
0.110
 Why?
Urban Population
1
2014
151
0.110
 Why?
Health Surveys
1
2014
232
0.110
 Why?
SEER Program
1
2013
98
0.110
 Why?
Organophosphonates
1
2013
7
0.110
 Why?
Testosterone
1
2013
139
0.110
 Why?
Perineum
1
2013
24
0.110
 Why?
Stress, Psychological
2
2019
260
0.110
 Why?
DNA, Viral
3
2020
133
0.110
 Why?
Placebos
1
2013
85
0.110
 Why?
Cytosine
1
2013
30
0.110
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.110
 Why?
tau Proteins
1
2012
26
0.110
 Why?
Piperazines
1
2013
117
0.110
 Why?
Prostate
2
2015
117
0.110
 Why?
HIV
3
2023
24
0.110
 Why?
Trichomonas Infections
1
2012
2
0.110
 Why?
Trichomonas vaginalis
1
2012
3
0.110
 Why?
Transforming Growth Factor beta1
1
2012
59
0.110
 Why?
Pyrimidines
1
2013
191
0.100
 Why?
Sleep
2
2024
182
0.100
 Why?
Vulvar Neoplasms
1
2013
52
0.100
 Why?
Time Factors
5
2023
2912
0.100
 Why?
Medicare
1
2013
244
0.100
 Why?
Androgen Antagonists
1
2011
11
0.100
 Why?
Urination Disorders
1
2011
23
0.100
 Why?
Sirolimus
1
2012
62
0.100
 Why?
CD8-Positive T-Lymphocytes
2
2017
115
0.100
 Why?
Antibiotics, Antineoplastic
1
2012
78
0.100
 Why?
Kenya
2
2022
11
0.100
 Why?
Quinazolinones
1
2011
6
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.090
 Why?
Practice Guidelines as Topic
1
2013
448
0.090
 Why?
Arkansas
1
2016
1967
0.090
 Why?
Social Class
1
2011
94
0.090
 Why?
Prognosis
5
2017
1952
0.090
 Why?
Methotrexate
2
2015
67
0.090
 Why?
Multivariate Analysis
1
2012
585
0.090
 Why?
Chronic Disease
1
2012
563
0.090
 Why?
Piperidines
1
2011
97
0.090
 Why?
Plant Bark
1
2009
6
0.090
 Why?
Colorectal Neoplasms
1
2013
234
0.090
 Why?
Multiple Myeloma
2
2014
2910
0.090
 Why?
Valproic Acid
1
2009
32
0.090
 Why?
Ki-67 Antigen
1
2009
57
0.090
 Why?
Socioeconomic Factors
1
2012
580
0.080
 Why?
India
2
2021
51
0.080
 Why?
Logistic Models
1
2012
891
0.080
 Why?
Tetracyclines
2
2006
7
0.080
 Why?
Fruit
1
2009
136
0.080
 Why?
Neoplasm Recurrence, Local
1
2012
618
0.080
 Why?
Cisplatin
2
2022
278
0.080
 Why?
Antiretroviral Therapy, Highly Active
3
2015
34
0.080
 Why?
Glomerulonephritis, IGA
1
2007
5
0.080
 Why?
Survival Analysis
3
2017
659
0.080
 Why?
Galactose
1
2007
28
0.080
 Why?
Immunoglobulin A
1
2007
45
0.080
 Why?
Adaptive Immunity
2
2017
31
0.080
 Why?
Glioblastoma
1
2009
91
0.070
 Why?
Sexual Partners
2
2018
28
0.070
 Why?
Disease Progression
4
2013
822
0.070
 Why?
Chaperonins
1
2006
3
0.070
 Why?
Regression Analysis
2
2018
395
0.070
 Why?
Chaperonin 60
1
2006
5
0.070
 Why?
Lymphocyte Count
1
2006
21
0.070
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.070
 Why?
Papillomavirus E7 Proteins
1
2006
31
0.070
 Why?
Viral Vaccines
1
2006
12
0.070
 Why?
Sexual Behavior
2
2018
116
0.070
 Why?
HIV Protease Inhibitors
1
2006
2
0.070
 Why?
Immunohistochemistry
3
2017
971
0.070
 Why?
Interferon-alpha
1
2006
47
0.070
 Why?
Nephrosis, Lipoid
1
2005
5
0.070
 Why?
Arterioles
1
2005
32
0.070
 Why?
Severity of Illness Index
2
2023
942
0.070
 Why?
Body Mass Index
2
2022
652
0.070
 Why?
Brain Neoplasms
1
2009
286
0.060
 Why?
Recombinant Fusion Proteins
1
2006
182
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
86
0.060
 Why?
Administration, Oral
4
2013
423
0.060
 Why?
Aminoimidazole Carboxamide
1
2004
3
0.060
 Why?
Phenotype
2
2017
727
0.060
 Why?
Leucovorin
1
2004
21
0.060
 Why?
Purines
1
2004
38
0.060
 Why?
Genotype
2
2017
538
0.060
 Why?
Neutropenia
2
2020
117
0.060
 Why?
Confidence Intervals
2
2015
156
0.060
 Why?
Dust
1
2024
22
0.060
 Why?
Particulate Matter
1
2024
52
0.060
 Why?
Arthritis, Rheumatoid
1
2004
105
0.060
 Why?
Carbon
1
2024
55
0.060
 Why?
Folic Acid
1
2004
135
0.060
 Why?
Cytochrome P-450 CYP3A
1
2023
78
0.060
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
5
0.050
 Why?
Hip
1
2003
25
0.050
 Why?
Drug Delivery Systems
1
2024
136
0.050
 Why?
Bacterial Proteins
1
2006
373
0.050
 Why?
Quality Control
1
2003
94
0.050
 Why?
Narcotics
1
2023
111
0.050
 Why?
Sample Size
1
2022
37
0.050
 Why?
Eating
1
2023
162
0.050
 Why?
Femur
1
2003
133
0.050
 Why?
Vitamins
1
2022
64
0.050
 Why?
Spine
1
2003
94
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
10
0.050
 Why?
Tetracycline
1
2002
20
0.050
 Why?
Radiotherapy Dosage
1
2022
243
0.050
 Why?
Vitamin D
1
2022
88
0.050
 Why?
Tretinoin
1
2002
53
0.050
 Why?
Leg
1
2022
122
0.050
 Why?
Fibroblast Growth Factor 2
2
2017
34
0.050
 Why?
Museums
1
2021
2
0.050
 Why?
Antibodies, Monoclonal
1
2005
458
0.050
 Why?
Regenerative Medicine
1
2021
9
0.050
 Why?
Alprostadil
1
2021
9
0.050
 Why?
Kidney
1
2005
665
0.050
 Why?
Length of Stay
1
2024
623
0.050
 Why?
Oxygen
1
2023
325
0.050
 Why?
Zimbabwe
1
2020
2
0.050
 Why?
Malawi
1
2020
10
0.050
 Why?
Wharton Jelly
1
2020
1
0.050
 Why?
Uganda
1
2020
36
0.050
 Why?
Herpesvirus 4, Human
1
2020
35
0.050
 Why?
Body Composition
1
2003
318
0.050
 Why?
Cell Shape
1
2020
20
0.050
 Why?
Software
1
2003
273
0.050
 Why?
Neisseria gonorrhoeae
1
2020
4
0.050
 Why?
Herpesviridae Infections
1
2020
46
0.050
 Why?
Ceftriaxone
1
2020
26
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
53
0.040
 Why?
B-Lymphocytes
1
2021
170
0.040
 Why?
Drug Resistance, Bacterial
1
2020
71
0.040
 Why?
Thrombocytopenia
1
2020
84
0.040
 Why?
Cohort Studies
2
2018
1422
0.040
 Why?
Remission Induction
2
2012
207
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Interleukin-6
2
2016
264
0.040
 Why?
Kaplan-Meier Estimate
1
2020
469
0.040
 Why?
Microbial Sensitivity Tests
1
2020
271
0.040
 Why?
Cell Survival
1
2020
598
0.040
 Why?
Masks
1
2018
30
0.040
 Why?
Statistics, Nonparametric
2
2013
197
0.040
 Why?
Receptors, Chemokine
1
2017
12
0.040
 Why?
Models, Animal
1
2019
233
0.040
 Why?
Coinfection
1
2018
38
0.040
 Why?
Neurodegenerative Diseases
1
2019
76
0.040
 Why?
Pandemics
1
2022
554
0.040
 Why?
Bone Marrow
1
2019
362
0.040
 Why?
Neurogenesis
1
2017
27
0.040
 Why?
Cell Separation
1
2017
88
0.040
 Why?
Cytological Techniques
1
2017
14
0.040
 Why?
Angiopoietin-2
1
2017
14
0.040
 Why?
Interleukin-2
1
2017
72
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Axilla
1
2017
89
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
43
0.040
 Why?
Fluorouracil
1
2016
55
0.040
 Why?
Staining and Labeling
1
2017
97
0.040
 Why?
Gene Rearrangement
1
2017
74
0.040
 Why?
Biopsy, Needle
1
2017
183
0.030
 Why?
Odds Ratio
1
2018
548
0.030
 Why?
Neuroprotective Agents
1
2017
105
0.030
 Why?
Chemoradiotherapy
1
2016
40
0.030
 Why?
Membrane Glycoproteins
1
2017
240
0.030
 Why?
Interferon-gamma
1
2017
174
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
5
0.030
 Why?
Mastectomy
1
2017
140
0.030
 Why?
Directly Observed Therapy
1
2015
8
0.030
 Why?
Urine
1
2015
23
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
18
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
RNA, Viral
2
2009
125
0.030
 Why?
Neoadjuvant Therapy
1
2017
115
0.030
 Why?
Neovascularization, Pathologic
1
2017
161
0.030
 Why?
Treatment Failure
1
2015
113
0.030
 Why?
Prisons
1
2015
38
0.030
 Why?
Infant
1
2024
3551
0.030
 Why?
Ifosfamide
1
2015
9
0.030
 Why?
Cytarabine
1
2015
39
0.030
 Why?
Flow Cytometry
1
2017
470
0.030
 Why?
Induction Chemotherapy
1
2014
60
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
57
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
20
0.030
 Why?
Depression
1
2019
564
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
36
0.030
 Why?
Melphalan
1
2014
174
0.030
 Why?
Statistics as Topic
1
2013
89
0.030
 Why?
Cancer Care Facilities
1
2013
20
0.030
 Why?
Time
1
2013
25
0.030
 Why?
Administration, Cutaneous
1
2013
49
0.030
 Why?
Infusions, Intravenous
1
2013
207
0.030
 Why?
Specialization
1
2013
46
0.030
 Why?
Molecular Targeted Therapy
1
2013
119
0.030
 Why?
Gene Expression Regulation
1
2017
979
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
55
0.030
 Why?
Demography
1
2013
93
0.030
 Why?
Antitrichomonal Agents
1
2012
1
0.030
 Why?
Risk Assessment
1
2017
1262
0.030
 Why?
Combined Modality Therapy
1
2014
636
0.030
 Why?
Reference Values
1
2013
310
0.030
 Why?
Polyethylene Glycols
1
2012
96
0.030
 Why?
Medical Oncology
1
2013
96
0.030
 Why?
Antigens, Viral
1
2012
44
0.030
 Why?
Administration, Topical
1
2011
54
0.020
 Why?
Single-Blind Method
1
2011
116
0.020
 Why?
Sex Factors
1
2013
693
0.020
 Why?
Organ Size
1
2011
226
0.020
 Why?
Neoplasm Proteins
1
2013
323
0.020
 Why?
Antibodies, Viral
1
2010
88
0.020
 Why?
Retrospective Studies
1
2022
6117
0.020
 Why?
Survival Rate
1
2012
905
0.020
 Why?
Anti-Retroviral Agents
1
2008
14
0.020
 Why?
Psychometrics
1
2009
220
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
319
0.020
 Why?
Lectins
1
2007
14
0.020
 Why?
Busulfan
1
2008
18
0.020
 Why?
Mutation
1
2013
1293
0.020
 Why?
Glycosylation
1
2007
100
0.020
 Why?
Mice
1
2017
5720
0.020
 Why?
Ultrasonography
1
2008
436
0.020
 Why?
Maximum Tolerated Dose
1
2006
37
0.020
 Why?
Injections, Subcutaneous
1
2006
52
0.020
 Why?
Hypertension, Renal
1
2005
22
0.020
 Why?
Cell Proliferation
1
2009
1007
0.020
 Why?
Fatigue
1
2006
118
0.020
 Why?
Pyridoxine
1
2004
4
0.020
 Why?
Ribonucleotides
1
2004
5
0.020
 Why?
Vitamin B 12
1
2004
27
0.020
 Why?
Erythrocytes
1
2004
79
0.020
 Why?
Recombinant Proteins
1
2006
486
0.010
 Why?
Adenosine
1
2004
69
0.010
 Why?
Homocysteine
1
2004
128
0.010
 Why?
Receptors, Interleukin-6
1
2002
22
0.010
 Why?
Endothelial Growth Factors
1
2002
9
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Drug Tolerance
1
2002
60
0.010
 Why?
Safety
1
2002
78
0.010
 Why?
Child, Preschool
1
2005
3853
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (462) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department